Thank you to our Sponsors
GOLD
GOLD
Pharmaceutical Host: Gina Oliveros
2024 & 2025 Sponsor (3 meetings)
Key prescription products:
Dupixent (dupilumab)
Xyzal Allergy 24 HR (levocetirizine)
Pharmaceutical Hosts: Deborah Wright & Evan Sitar
2024 & 2025 Sponsor
Key prescription products:
Ruconest (conestat alfa: C1 esterase inhibitor)
Joenja (leniolisib)
Pharmaceutical Host: Lori Solomon
2024 & 2025 Sponsor
Key prescription products:
Xhance (fluticasone propionate nasal spray)
Note: Optinose acquired by Paratek on 5.21.25
Pharmaceutical Host: Candice Zizilas
2025 Sponsor
Key prescription products:
Neffy (epinephrine nasal spray)
Pharmaceutical Host: Nicole Frucht
2025 Sponsor
Key prescription products:
Ekterly (sebetralstat)
Pharmaceutical Host: Ashley Bailey
2024 Sponsor
Key prescription products:
Xolremdi™ (Mavorixafor) for Whim's Syndrome
Pharmaceutical Host: Lorraine Ozerovitch
2024 Sponsor
Key prescription products:
Xembofy (Gammaglobulin subcut)
Pharmaceutical Host: J, Judd Hobgood
2024 Sponsor
Key prescription products:
ASCENIV (Immune Globulin IV)
BIVIGAM (Immune Globulin IV)
Pharmaceutical Host: Robyn Roche
2024 & 2025 Sponsor
Key prescription products:
AYVAKIT (avapritinib)
Pharmaceutical Host: Miguel Quintana
2024 & 2025 Sponsor
Key prescription products:
Orladeyo (berostralstat)
Pharmaceutical Host: Jacob Romano & Holli Feller
2025 Sponsor
Key prescription products:
Andembry (garadacimab-gxii)
Hizentra (immuneglobulin subcut.)
Haegarda (C1 esterase Inh. subcut.)
Privigen (immunoglobulin IV)
Berinert (C1 esterase Inh. IV)
Pharmaceutical Host: Shakeera Mustapha
2025 Sponsor
Key prescription products:
Nemluvio (nemolizumab)
Pharmaceutical Host: Dawn East
2024 Sponsor
Key prescription products:
Takhzyro® (lanadelumab)
EOHILIA (budesonide oral suspension)
Pharmaceutical Host: Jay Chatfield
2024 Sponsor
Key prescription products:
Benzuclastinib (tyrosine kinase inhibitor targeting KIT F816V mutations) currently under development.
Pharmaceutical Host: Wendi Bachman
2024 Sponsor
Key prescription products:
Xolair (omalizumab)
Esbriet (pirfenidone) for Idiopathic Pulmonary Fibrosis
Become a Sponsor
Your support is vital to our mission.
For sponsorship opportunities, contact Dr. Dana Wallace or Dr. Shahnaz Fatteh